144 related articles for article (PubMed ID: 35588715)
1. Comparison of Stroke Risk Factors between Symptomatic and Asymptomatic Patients in a North American Moyamoya Disease Cohort.
Kumar M; Larson A; Jabal MS; Rinaldo L; Savastano L; Lanzino G; Meyer F; Lehman V; Klaas J
Cerebrovasc Dis Extra; 2022; 12(2):72-75. PubMed ID: 35588715
[TBL] [Abstract][Full Text] [Related]
2. The natural history of moyamoya in a North American adult cohort.
Gross BA; Du R
J Clin Neurosci; 2013 Jan; 20(1):44-8. PubMed ID: 23146211
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of and Risk Factors for Cerebral Microbleeds in Moyamoya Disease and Syndrome in the American Population.
Khan NI; Saherwala AA; Chen M; Salehian S; Salahuddin H; Welch BG; Pinho MC; Shang T
Cerebrovasc Dis Extra; 2019; 9(3):139-147. PubMed ID: 31830749
[TBL] [Abstract][Full Text] [Related]
4. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors.
Unda SR; Antoniazzi AM; Miller R; Klyde D; Javed K; Fluss R; Holland R; De la Garza Ramos R; Haranhalli N; Altschul DJ
J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105965. PubMed ID: 34247053
[TBL] [Abstract][Full Text] [Related]
5. Development of Hemorrhage-prone Anastomoses in Asymptomatic Moyamoya Disease-A Comparative Study with Japan Adult Moyamoya Trial.
Yamamoto S; Funaki T; Fujimura M; Takahashi JC; Uchino H; Houkin K; Tominaga T; Miyamoto S; Kuroda S;
J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104328. PubMed ID: 31471213
[TBL] [Abstract][Full Text] [Related]
6. The natural clinical course of hemodynamically stable adult moyamoya disease.
Cho WS; Chung YS; Kim JE; Jeon JP; Son YJ; Bang JS; Kang HS; Sohn CH; Oh CW
J Neurosurg; 2015 Jan; 122(1):82-9. PubMed ID: 25361479
[TBL] [Abstract][Full Text] [Related]
7. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
[TBL] [Abstract][Full Text] [Related]
8. Asymptomatic Moyamoya Disease in a North American Adult Cohort.
Lai PMR; Gomez-Paz S; Patel NJ; Frerichs KU; Thomas AJ; Aziz-Sultan MA; Patel AB; Ogilvy CS; Du R
World Neurosurg; 2022 May; 161():e146-e153. PubMed ID: 35092810
[TBL] [Abstract][Full Text] [Related]
9. Clinical Characteristics and Natural History of Quasi-Moyamoya Disease.
Zhao M; Lin Z; Deng X; Zhang Q; Zhang D; Zhang Y; Wang R; Wang S; Jiang Z; Wang H; Zhao J
J Stroke Cerebrovasc Dis; 2017 May; 26(5):1088-1097. PubMed ID: 28109734
[TBL] [Abstract][Full Text] [Related]
10. Angiographic and Hemodynamic Features in Asymptomatic Hemispheres of Patients With Moyamoya Disease.
Sun H; Li W; Xia C; Ren Y; Ma L; Xiao A; You C; Liu Y; Tian R
Stroke; 2022 Jan; 53(1):210-217. PubMed ID: 34547926
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
[TBL] [Abstract][Full Text] [Related]
12. Comparison between moyamoya disease and moyamoya syndrome in Israel.
Schwartzmann Y; Spektor S; Moscovici S; Jubran H; Metanis I; Jouaba T; Cohen JE; Gomori JM; Leker RR
J Stroke Cerebrovasc Dis; 2024 Apr; 33(4):107635. PubMed ID: 38342272
[TBL] [Abstract][Full Text] [Related]
13. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.
Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM
J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597
[TBL] [Abstract][Full Text] [Related]
14. Impact of Interethnic Difference of Collateral Angioarchitectures on Prevalence of Hemorrhagic Stroke in Moyamoya Disease.
Hori S; Kashiwazaki D; Yamamoto S; Acker G; Czabanka M; Akioka N; Kuwayama N; Vajkoczy P; Kuroda S
Neurosurgery; 2019 Jul; 85(1):134-146. PubMed ID: 29889273
[TBL] [Abstract][Full Text] [Related]
15. Clinical course of asymptomatic adult moyamoya disease.
Jo KI; Yeon JY; Hong SC; Kim JS
Cerebrovasc Dis; 2014; 37(2):94-101. PubMed ID: 24435045
[TBL] [Abstract][Full Text] [Related]
16. Results of Conservative Follow-up or Surgical Treatment of Moyamoya Patients Who Present without Hemorrhage, Transient Ischemic Attack, or Stroke.
Luo R; Gao F; Deng X; Zhang D; Zhang Y
World Neurosurg; 2017 Dec; 108():683-689. PubMed ID: 28927919
[TBL] [Abstract][Full Text] [Related]
17. Five-Year Stroke Risk and Its Predictors in Asymptomatic Moyamoya Disease: Asymptomatic Moyamoya Registry (AMORE).
Kuroda S; Yamamoto S; Funaki T; Fujimura M; Kataoka H; Hishikawa T; Takahashi J; Endo H; Nariai T; Osato T; Saito N; Sato N; Hori E; Ito YM; Miyamoto S;
Stroke; 2023 Jun; 54(6):1494-1504. PubMed ID: 37216455
[TBL] [Abstract][Full Text] [Related]
18. High Prevalence of Moyamoya Syndrome in Appalachia.
Nisiewicz MJ; Roberts JM; Dobbs MR; Ajadi EA; Kitzman P; Wolfe M; Elkins K; Dugan AJ; Fraser JF
Cerebrovasc Dis; 2020; 49(5):516-521. PubMed ID: 33027801
[TBL] [Abstract][Full Text] [Related]
19. Direct vs Indirect Revascularization in a North American Cohort of Moyamoya Disease.
Lai PMR; Patel NJ; Frerichs KU; Patel AB; Aziz-Sultan MA; Ogilvy CS; Du R
Neurosurgery; 2021 Jul; 89(2):315-322. PubMed ID: 33957674
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Operative and Conservative Treatment for Asymptomatic Moyamoya Disease: Preliminary Experience in Small Retrospective Series.
Zeng H; Guo Y; Li Y; Yu X; Yan F; Tan X; Xu H; Peng Y; Zhuang J; Zhou H; Fu X; Wang L; Chen G
World Neurosurg; 2021 Feb; 146():e955-e960. PubMed ID: 33217589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
